STAT5A and cancer: In support of this concept, our data showed that the cancer-related activating mutations I699L and Q701L located in interface 2 of the STAT5A molecule indeed resulted in elevated dimerization levels, but remained highly susceptible to alteration of the F706 residue (Fig. 5c,d).